Barrow Hanley Mewhinney & Strauss LLC raised its stake in shares of Invacare Corporation (NYSE:IVC) by 654.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,383,222 shares of the health services provider’s stock after purchasing an additional 2,067,186 shares during the quarter. Barrow Hanley Mewhinney & Strauss LLC owned approximately 6.08% of Invacare worth $37,535,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of the business. Perceptive Advisors LLC purchased a new position in Invacare during the 3rd quarter valued at $3,950,000. Harvey Partners LLC increased its position in Invacare by 860.6% during the 3rd quarter. Harvey Partners LLC now owns 126,800 shares of the health services provider’s stock valued at $1,997,000 after purchasing an additional 113,600 shares during the period. Keeley Teton Advisors LLC increased its position in Invacare by 1,779.1% during the 3rd quarter. Keeley Teton Advisors LLC now owns 442,715 shares of the health services provider’s stock valued at $6,973,000 after purchasing an additional 419,155 shares during the period. Royce & Associates LP increased its position in Invacare by 4.4% during the 3rd quarter. Royce & Associates LP now owns 1,414,169 shares of the health services provider’s stock valued at $22,273,000 after purchasing an additional 59,430 shares during the period. Finally, Engineers Gate Manager LP increased its position in Invacare by 33.4% during the 3rd quarter. Engineers Gate Manager LP now owns 52,387 shares of the health services provider’s stock valued at $825,000 after purchasing an additional 13,119 shares during the period. 94.65% of the stock is currently owned by institutional investors and hedge funds.
IVC has been the topic of a number of research analyst reports. KeyCorp reissued an “overweight” rating and set a $17.00 price objective on shares of Invacare in a research report on Tuesday, September 26th. Zacks Investment Research raised shares of Invacare from a “sell” rating to a “hold” rating in a research report on Wednesday, October 11th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $15.00.
Invacare (NYSE:IVC) last released its earnings results on Tuesday, November 7th. The health services provider reported ($0.41) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.43) by $0.02. The firm had revenue of $250.91 million for the quarter, compared to the consensus estimate of $239.88 million. Invacare had a negative net margin of 7.95% and a negative return on equity of 13.33%. The company’s revenue was down 6.4% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.37) EPS. sell-side analysts expect that Invacare Corporation will post -2 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 16th. Stockholders of record on Thursday, January 4th will be given a $0.0125 dividend. This represents a $0.05 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date of this dividend is Wednesday, January 3rd. Invacare’s dividend payout ratio is presently -2.13%.
Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.
Want to see what other hedge funds are holding IVC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invacare Corporation (NYSE:IVC).
What are top analysts saying about Invacare? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Invacare and related companies.